Clinical Diagnostics Potential Telomere Diagnostics operates a CLIA-certified high throughput clinical diagnostics lab focused on COVID-19 testing with saliva and nasal PCR, presenting opportunities to expand into additional infectious disease panels or routine surveillance partnerships for healthcare providers and employers seeking scalable testing.

Smaller Firm, Big Reach With a small team and national scale capabilities, Telomere Diagnostics can partner with larger labs or healthcare networks to augment throughput, offer white-label testing solutions, or provide turnkey data reporting to reduce partner burden.

Telomere Test Brand Telomere Diagnostics has a recognized telomere test product (TeloYears) and a Nobel-linked origin story, which can be leveraged to co-market premium genetic/biomarker testing services to precision medicine initiatives and corporate wellness programs.

Revenue Growth Levers Current revenue positioned in the low-to-mid millions suggests growth potential through expanded test menus, contract-based lab services, and regional or national contracts with clinics, employers, or health plans seeking scalable PCR testing and reporting.

Strategic Partnership Fit The company’s CLIA-certified lab operations, digital reporting capabilities, and national collection/reporting solution align well with larger reference labs and diagnostics distributors looking to broaden assay offerings and improve turnaround times for clients.